Berman McAleer’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$697K Sell
4,315
-71
-2% -$11.8K 0.08% 85
2026
Q2
$832K Buy
4,386
+55
+1% +$10.3K 0.1% 76
2026
Q1
$854K Sell
4,331
-5
-0.1% -$964 0.12% 68
2025
Q4
$797K Buy
4,336
+6
+0.1% +$1.05K 0.11% 71
2025
Q3
$664K Hold
4,330
– – 0.09% 77

Other funds holding AZN

Berman McAleer's AZN Position: Q3 2026 in Review

Berman McAleer reduced its AstraZeneca (AZN) stake by 1.6% in Q3 2026, selling an estimated $11.8K and leaving 4,315 shares worth $697K. The position accounts for 0.08% of the portfolio, ranked #85.

Berman McAleer first reported a position in AZN in Q3 2025 and has held it in 5 quarters since. The position peaked at $854K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Berman McAleer held 4,315 shares of AstraZeneca worth $697K as of Q3 2026.
  • Berman McAleer sold 71 AstraZeneca shares in Q3 2026, an estimated $11.8K.
  • AstraZeneca made up 0.08% of Berman McAleer's portfolio in Q3 2026, its #85 holding.
  • Berman McAleer first reported a position in AstraZeneca in Q3 2025 and has held it in 5 quarters since.
  • Berman McAleer's AstraZeneca position peaked at $854K in Q1 2026.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Berman McAleer's 13F filing for Q3 2026, filed 16 Oct 2026.